Avidity Partners Management as of June 30, 2023
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 93 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Becton, Dickinson and (BDX) | 3.7 | $105M | 398k | 264.01 | |
| Karuna Therapeutics Ord | 3.3 | $96M | 442k | 216.85 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.0 | $87M | 703k | 123.97 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 3.0 | $85M | 1.0M | 81.24 | |
| Tenet Healthcare Corp Com New (THC) | 2.8 | $81M | 991k | 81.38 | |
| Argenx Se Sponsored Adr (ARGX) | 2.5 | $72M | 184k | 389.73 | |
| Ideaya Biosciences (IDYA) | 2.5 | $70M | 3.0M | 23.50 | |
| Surgery Partners (SGRY) | 2.4 | $70M | 1.6M | 44.99 | |
| Abbvie (ABBV) | 2.4 | $70M | 518k | 134.73 | |
| Arvinas Ord (ARVN) | 2.4 | $69M | 2.8M | 24.82 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.3 | $66M | 2.3M | 28.21 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $63M | 665k | 94.30 | |
| Eli Lilly & Co. (LLY) | 2.2 | $62M | 133k | 468.98 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $60M | 2.9M | 20.93 | |
| Universal Hlth Svcs CL B (UHS) | 2.0 | $58M | 370k | 157.77 | |
| Bio Rad Labs Cl A (BIO) | 2.0 | $58M | 153k | 379.12 | |
| AmerisourceBergen (COR) | 2.0 | $58M | 300k | 192.43 | |
| Pacific Biosciences of California (PACB) | 2.0 | $58M | 4.3M | 13.30 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.9 | $55M | 799k | 69.03 | |
| Biogen Idec (BIIB) | 1.7 | $50M | 174k | 284.85 | |
| Akero Therapeutics (AKRO) | 1.7 | $48M | 1.0M | 46.69 | |
| Curevac N V (CVAC) | 1.6 | $45M | 4.3M | 10.42 | |
| Acadia Healthcare (ACHC) | 1.5 | $44M | 550k | 79.64 | |
| Vaxcyte (PCVX) | 1.5 | $44M | 875k | 49.94 | |
| McKesson Corporation (MCK) | 1.5 | $43M | 101k | 427.31 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $43M | 469k | 91.10 | |
| Boston Scientific Corporation (BSX) | 1.5 | $43M | 786k | 54.09 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $42M | 901k | 46.13 | |
| Pfizer (PFE) | 1.4 | $41M | 1.1M | 36.68 | |
| Immunovant (IMVT) | 1.4 | $40M | 2.1M | 18.97 | |
| Axsome Therapeutics (AXSM) | 1.4 | $39M | 545k | 71.86 | |
| ImmunoGen | 1.3 | $38M | 2.0M | 18.87 | |
| Zoetis Cl A (ZTS) | 1.3 | $37M | 217k | 172.21 | |
| Prothena Corp SHS (PRTA) | 1.3 | $37M | 535k | 68.28 | |
| Vir Biotechnology (VIR) | 1.2 | $35M | 1.4M | 24.53 | |
| Immunocore Hldgs Ads (IMCR) | 1.2 | $35M | 575k | 59.96 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $34M | 298k | 114.52 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $33M | 925k | 35.66 | |
| Biohaven (BHVN) | 1.1 | $32M | 1.3M | 23.92 | |
| Revolution Medicines (RVMD) | 1.0 | $29M | 1.1M | 26.75 | |
| Privia Health Group (PRVA) | 1.0 | $28M | 1.1M | 26.11 | |
| Phathom Pharmaceuticals (PHAT) | 1.0 | $28M | 1.9M | 14.32 | |
| Baxter International (BAX) | 1.0 | $28M | 605k | 45.56 | |
| Fusion Pharmaceuticals (FUSN) | 0.9 | $27M | 5.7M | 4.67 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $26M | 1.3M | 19.87 | |
| Blueprint Medicines (BPMC) | 0.9 | $26M | 415k | 63.20 | |
| Editas Medicine (EDIT) | 0.9 | $25M | 3.0M | 8.23 | |
| Ventyx Biosciences (VTYX) | 0.8 | $23M | 693k | 32.80 | |
| Natera (NTRA) | 0.7 | $21M | 433k | 48.66 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $21M | 245k | 83.92 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.7 | $20M | 400k | 51.00 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.7 | $20M | 955k | 21.14 | |
| Amylyx Pharmaceuticals (AMLX) | 0.7 | $19M | 901k | 21.57 | |
| Axonics Modulation Technolog (AXNX) | 0.7 | $19M | 380k | 50.47 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $19M | 481k | 38.50 | |
| Regeneron Pharmaceuticals (REGN) | 0.6 | $18M | 25k | 718.54 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $17M | 1.7M | 10.08 | |
| Pliant Therapeutics (PLRX) | 0.6 | $17M | 917k | 18.12 | |
| Verve Therapeutics (VERV) | 0.6 | $17M | 879k | 18.75 | |
| Intellia Therapeutics (NTLA) | 0.6 | $16M | 396k | 40.78 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.6 | $16M | 501k | 31.79 | |
| Acelyrin (SLRN) | 0.5 | $16M | 750k | 20.90 | |
| Point Biopharma Global | 0.5 | $15M | 1.7M | 9.06 | |
| Karyopharm Therapeutics (KPTI) | 0.5 | $15M | 8.4M | 1.79 | |
| Kezar Life Sciences (KZR) | 0.5 | $15M | 6.1M | 2.45 | |
| Schrodinger (SDGR) | 0.5 | $14M | 275k | 49.92 | |
| 2seventy Bio Common Stock (TSVT) | 0.5 | $14M | 1.3M | 10.12 | |
| Mineralys Therapeutics (MLYS) | 0.5 | $13M | 767k | 17.05 | |
| Mersana Therapeutics (MRSN) | 0.4 | $13M | 3.8M | 3.29 | |
| Caribou Biosciences (CRBU) | 0.4 | $12M | 2.8M | 4.25 | |
| Nanostring Technologies (NSTGQ) | 0.4 | $11M | 2.7M | 4.05 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $11M | 1.1M | 10.28 | |
| Inari Medical Ord (NARI) | 0.4 | $10M | 175k | 58.14 | |
| 89bio (ETNB) | 0.3 | $10M | 526k | 18.95 | |
| Ac Immune Sa SHS (ACIU) | 0.3 | $8.6M | 2.9M | 2.96 | |
| Denali Therapeutics (DNLI) | 0.3 | $8.3M | 283k | 29.51 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $7.6M | 354k | 21.49 | |
| Alphatec Hldgs Com New (ATEC) | 0.2 | $7.1M | 393k | 17.98 | |
| An2 Therapeutics (ANTX) | 0.2 | $5.6M | 657k | 8.50 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $5.4M | 2.8M | 1.95 | |
| Compass Therapeutics (CMPX) | 0.2 | $5.2M | 1.6M | 3.18 | |
| Scynexis Com New (SCYX) | 0.2 | $5.1M | 1.7M | 2.95 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.2 | $4.6M | 1.5M | 3.15 | |
| Altimmune Com New (ALT) | 0.1 | $4.1M | 1.2M | 3.53 | |
| Century Therapeutics (IPSC) | 0.1 | $3.5M | 1.1M | 3.16 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $2.6M | 1.2M | 2.15 | |
| Simulations Plus (SLP) | 0.1 | $2.0M | 46k | 43.33 | |
| Caremax Com Cl A | 0.1 | $2.0M | 636k | 3.11 | |
| Bausch Health Companies (BHC) | 0.1 | $1.7M | 215k | 8.00 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $1.6M | 38k | 41.57 | |
| Exscientia Ads (EXAI) | 0.0 | $755k | 128k | 5.92 | |
| Arteris (AIP) | 0.0 | $515k | 76k | 6.82 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $15k | 91k | 0.17 |
